The Stony Brook Press, February 2020
Why These Long Island Doctors Are Giving Their Patients Ketamine
Lucian Manu, MD, Director of the Stony Brook Treatment Resistant Depression Program, served as Principal Investigator for the Janssen Pharmaceutical clinical trial for esketamine at Stony Brook University (2017-2019), which helped lead to it receiving the designation of "breakthrough therapy" in 2019 by the Food and Drug Administration.